Avanos Medical AVNS Selling General And Administrative Expense
Selling General And Administrative Expense at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's selling general and administrative expense?
- Avanos Medical (AVNS) reported selling general and administrative expense of $77.7M in Q1 2026.
- How has Avanos Medical's selling general and administrative expense changed year-over-year?
- Avanos Medical's selling general and administrative expense increased by 2.6% year-over-year, from $75.7M to $77.7M.
- What is the long-term trend for Avanos Medical's selling general and administrative expense?
- Over 4 years (2021 to 2025), Avanos Medical's selling general and administrative expense has grown at a 2.6% compound annual growth rate (CAGR), from $285.3M to $315.6M.
- What does selling general and administrative expense mean?
- Covers the costs of supporting functions, including sales force compensation, marketing, legal, and general corporate overhead. This metric is critical for evaluating the company's operational leverage and the efficiency of its commercial organization.